Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label…

Overview of attention for article published in Diabetes Therapy, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 34,509 followers.

RT @DanielJDrucker: Canagliflozon and glucose control #T2D Does GLP-1 contribute? https://t.co/WKz1qsIPrp

Reply Repost Favourite

Canagliflozon and glucose control #T2D Does GLP-1 contribute? https://t.co/WKz1qsIPrp

Reply Repost Favourite